57894-225 : Inlexzo 225 mg Intravesical System
| NDC: | 57894-225 |
| Labeler: | Janssen Biotech, Inc |
| Product Type: | Human Prescription Drug |
| Drug Name: | Inlexzo |
| Dosage Form: | Intravesical System |
| Application #: | NDA219683 |
| Rev. Date: |
NDC Package Codes:
- 57894-225-01: 1 SYSTEM IN 1 BOX (57894‑225‑01)
- 57894-225-99: 1 SYSTEM IN 1 BOX (57894‑225‑99)
Active Ingredients:
- Gemcitabine
Dosage Strength:
- 225 mg
Pharmaceutical Classes:
- Nucleic Acid Synthesis Inhibitors [MoA]
- Nucleoside Metabolic Inhibitor [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 57894-200Next: 57894-240 >
Related Discussions:
GEMCITABINE/GEMZAK
CHEMOTHERAPY ## What is the dosage of gemcitabin + Mannitol +Sodium Acetate Combination... 1 reply
CHEMOTHERAPY ## What is the dosage of gemcitabin + Mannitol +Sodium Acetate Combination... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.